- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Time Scale Calculus: a new approach to multi-dose pharmacokinetic modeling ; day:25 ; month:7 ; year:2024 ; pages:1-15
Journal of pharmacokinetics and pharmacodynamics ; (25.7.2024), 1-15
- Urheber
-
Arteaga-Bejarano, José Ricardo
Torres, Santiago
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10928-024-09920-z
- URN
-
urn:nbn:de:101:1-2410112100092.068235028547
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Arteaga-Bejarano, José Ricardo
- Torres, Santiago
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Population pharmacokinetic modeling to understand antineoplastic treatment
Fractional q-Calculus on a time scale
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
Assessing Dose-Exposure–Response Relationships of Miltefosine in Adults and Children using Physiologically-Based Pharmacokinetic Modeling Approach
Dose Rationale of Nasal Glucagon in Japanese Pediatric Patients with Diabetes Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Fractional q-symmetric calculus on a time scale
Hilbert-type inequalities for time scale nabla calculus
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Population pharmacokinetic modeling to understand antineoplastic treatment
Fractional q-Calculus on a time scale
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
Assessing Dose-Exposure–Response Relationships of Miltefosine in Adults and Children using Physiologically-Based Pharmacokinetic Modeling Approach
Dose Rationale of Nasal Glucagon in Japanese Pediatric Patients with Diabetes Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Fractional q-symmetric calculus on a time scale
Hilbert-type inequalities for time scale nabla calculus
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Population pharmacokinetic modeling to understand antineoplastic treatment
Fractional q-Calculus on a time scale
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
Assessing Dose-Exposure–Response Relationships of Miltefosine in Adults and Children using Physiologically-Based Pharmacokinetic Modeling Approach
Dose Rationale of Nasal Glucagon in Japanese Pediatric Patients with Diabetes Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Fractional q-symmetric calculus on a time scale
Hilbert-type inequalities for time scale nabla calculus
A minimal physiologically based pharmacokinetic model for high-dose methotrexate